Biodistribution, radiation dosimetry and scouting of Y-90-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using Zr-89-ibritumomab tiuxetan and PET

S.N.F. Rizvi; O. Visser; M.J.W.D. Vosjan; A. van Lingen; O.S. Hoekstra; J.M. Zijlstra-Baalbergen; P.C. Huijgens; G.A.M.S. van Dongen; J.M. Lubberink

doi:https://doi.org/10.1007/s00259-011-2008-5

Biodistribution, radiation dosimetry and scouting of Y-90-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using Zr-89-ibritumomab tiuxetan and PET

S.N.F. Rizvi, O. Visser, M.J.W.D. Vosjan, A. van Lingen, O.S. Hoekstra, J.M. Zijlstra-Baalbergen, P.C. Huijgens, G.A.M.S. van Dongen, J.M. Lubberink

Research output: Contribution to journal › Article › Academic › peer-review

86 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	512-520
Journal	European journal of nuclear medicine and molecular imaging
Volume	39
Issue number	3
DOIs	https://doi.org/10.1007/s00259-011-2008-5
Publication status	Published - 2012

Access to Document

https://doi.org/10.1007/s00259-011-2008-5

Cite this

Rizvi, S. N. F., Visser, O., Vosjan, M. J. W. D., van Lingen, A., Hoekstra, O. S., Zijlstra-Baalbergen, J. M., Huijgens, P. C., van Dongen, G. A. M. S., & Lubberink, J. M. (2012). Biodistribution, radiation dosimetry and scouting of Y-90-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using Zr-89-ibritumomab tiuxetan and PET. European journal of nuclear medicine and molecular imaging, 39(3), 512-520. https://doi.org/10.1007/s00259-011-2008-5

@article{4b6ccf9309284144a62aa9cf8ae52eac,

title = "Biodistribution, radiation dosimetry and scouting of Y-90-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using Zr-89-ibritumomab tiuxetan and PET",

author = "S.N.F. Rizvi and O. Visser and M.J.W.D. Vosjan and {van Lingen}, A. and O.S. Hoekstra and J.M. Zijlstra-Baalbergen and P.C. Huijgens and {van Dongen}, G.A.M.S. and J.M. Lubberink",

year = "2012",

doi = "https://doi.org/10.1007/s00259-011-2008-5",

language = "Undefined/Unknown",

volume = "39",

pages = "512--520",

journal = "European journal of nuclear medicine and molecular imaging",

issn = "1619-7070",

publisher = "Springer Verlag",

number = "3",

}

Rizvi, SNF, Visser, O, Vosjan, MJWD, van Lingen, A, Hoekstra, OS, Zijlstra-Baalbergen, JM , Huijgens, PC , van Dongen, GAMS & Lubberink, JM 2012, 'Biodistribution, radiation dosimetry and scouting of Y-90-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using Zr-89-ibritumomab tiuxetan and PET', European journal of nuclear medicine and molecular imaging, vol. 39, no. 3, pp. 512-520. https://doi.org/10.1007/s00259-011-2008-5

Biodistribution, radiation dosimetry and scouting of Y-90-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using Zr-89-ibritumomab tiuxetan and PET. / Rizvi, S.N.F.; Visser, O.; Vosjan, M.J.W.D. et al.
In: European journal of nuclear medicine and molecular imaging, Vol. 39, No. 3, 2012, p. 512-520.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Biodistribution, radiation dosimetry and scouting of Y-90-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using Zr-89-ibritumomab tiuxetan and PET

AU - Rizvi, S.N.F.

AU - Visser, O.

AU - Vosjan, M.J.W.D.

AU - van Lingen, A.

AU - Hoekstra, O.S.

AU - Zijlstra-Baalbergen, J.M.

AU - Huijgens, P.C.

AU - van Dongen, G.A.M.S.

AU - Lubberink, J.M.

PY - 2012

Y1 - 2012

U2 - https://doi.org/10.1007/s00259-011-2008-5

DO - https://doi.org/10.1007/s00259-011-2008-5

M3 - Article

C2 - 22218876

SN - 1619-7070

VL - 39

SP - 512

EP - 520

JO - European journal of nuclear medicine and molecular imaging

JF - European journal of nuclear medicine and molecular imaging

IS - 3

ER -

Rizvi SNF, Visser O, Vosjan MJWD, van Lingen A, Hoekstra OS, Zijlstra-Baalbergen JM et al. Biodistribution, radiation dosimetry and scouting of Y-90-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using Zr-89-ibritumomab tiuxetan and PET. European journal of nuclear medicine and molecular imaging. 2012;39(3):512-520. doi: https://doi.org/10.1007/s00259-011-2008-5